Navigation Links
UC San Diego's 'Biotech Demystified' Program Offers Science Basics for Industry Leaders
Date:3/1/2010

LA JOLLA, Calif., March 1 /PRNewswire-USNewswire/ -- The University of California, San Diego will present its seventh offering of Biotech Demystified June 7-9. This innovative program helps executives and decision makers gain a practical understanding of the basic science powering the biotechnology and pharmaceutical industries. The program is offered through the Rady School of Management Center for Executive Development in collaboration with the Division of Biological Sciences and the Skaggs School of Pharmacy and Pharmaceutical Sciences.

"The major thing that attendees gain is a context for understanding biotechnology as both a discipline and a business," says UC San Diego biology Professor Steve Wasserman, one of the program's instructors. "We give attendees a focused introduction to the science behind biotechnology, with examples drawn from the biotech industry.  We help them see problems and approaches from a scientist's point of view. Biotech Demystified is a very focused program, but offers broad perspectives from San Diego's biotech community."

Featured instructors include nine faculty members from UC San Diego, one of the nation's leading research institutions. The course covers science fundamentals, stem cell research, risk management in life sciences, pharmacogenomics and personalized medicine, and cancer and therapeutic approaches.  It also includes hands-on exercises in the lab setting.

"The information I present can save the attendee hours if not days of effort if they were to seek it on their own," says Professor Jean Wang of UCSD Moores Cancer Center, who provides an updated overview of cancer and oncology for program participants.  "By providing the biotech professionals with the framework of oncology, I aim to facilitate innovation in the biotech sector to tackle the cancer problem."

Biotech Demystified is designed for CEOs and executives, venture capitalists and angel investors, service providers including consultants, attorneys, insurance brokers and real estate professionals, marketing and sales professionals, government officials, executive recruiters and journalists covering related industries.

The Rady School of Management at UC San Diego educates global leaders for innovation-driven organizations. A professional school within one of the top-ranked institutions in the U.S. for higher education and research, the Rady School offers a Full-Time MBA program, a FlexMBA program for working professionals, a Ph.D. program, and undergraduate and executive education courses.

To learn more or to register for the program, visit http://rady.ucsd.edu/exec/open/biotech/.

SOURCE UC San Diego Rady School of Management

Back to top
'/>"/>
SOURCE UC San Diego Rady School of Management
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
3. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
4. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
5. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
10. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
11. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:6/22/2016)... 2016 On Monday, the Department of Homeland ... share solutions for the Biometric Exit Program. The Request ... Protection (CBP), explains that CBP intends to add biometrics ... the United States , in order to deter ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
Breaking Biology News(10 mins):